Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04533425 · ClinicalTrials.gov registry record

Practical Approaches to Care in Emergency Syncope

A clinical trial of Syncope and Presyncope, sponsored by Columbia University.

Completed
Registry status
1,297
Enrollment target
5
Study locations

NCT04533425 is a study of Syncope and Presyncope that has completed, run by Columbia University. The registered enrollment target is 1,297 participants, above the 733-participant average among 11 other Syncope trials with a reported enrollment target (77% higher). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04533425, a study of Syncope and Presyncope, has completed, sponsored by Columbia University.

COMPLETED
Registry status
1,297 participants
Enrollment target
5
Study locations

Study Summary

Syncope, or transient loss of consciousness, is a common reason for visit to the Emergency Department and often leads to extensive testing and hospitalization. Using objective risk scores to determine which patients with syncope will actually benefit from these interventions, and which can be safely discharged home with minimal testing, is critical to providing sensible medical care. This study will evaluate the validity of two syncope risk-stratification tools and investigate their impact on healthcare utilization and patient safety, thus improving the quality of care for the 1-2 million patients who experience syncope every year in the United States

Conditions Studied

Study Locations (5)

New York

  • Icahn School of Medicine at Mount Sinai - New York
  • Columbia University Irving Medical Center - New York
  • University of Rochester - Rochester

California

  • UC Davis - Sacramento

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 1,297 participants
Start Date 2020-09-14
Est. Completion 2024-09-30

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT04533425

The ClinicalTrials.gov registry entry for NCT04533425 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,297 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 733-participant average among 11 other Syncope trials with a reported enrollment target (77% higher). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Syncope appearing as the primary indexed condition, and to 0 interventions.

NCT04533425 reports 5 study locations spanning 3 distinct geographic areas - top geographies include New York, California, Tennessee.

Frequently Asked Questions

What is clinical trial NCT04533425 about?

NCT04533425 is a clinical study titled "Practical Approaches to Care in Emergency Syncope". Syncope, or transient loss of consciousness, is a common reason for visit to the Emergency Department and often leads to extensive testing and hospitalization. Using objective risk scores to determine which patients with syncope will actually benefit from these interventions, and which can be safely...

What is the current status of trial NCT04533425?

This trial is currently completed. The enrollment target is 1,297 participants. The study started on 2020-09-14. Estimated completion is 2024-09-30.

What conditions does trial NCT04533425 study?

This clinical trial studies the following conditions: Syncope, Presyncope.

Who is sponsoring clinical trial NCT04533425?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04533425 being conducted?

This trial has 5 study locations across California, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Syncope

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.